Narrow search
Showing 1 - 10 of 216
Cover Image
Pharmaceutical Patents : Incentives for R&D or Marketing?
Brekke, Kurt Richard; Straume, Odd Rune - 2021
We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R … industry. Within a fairly general model framework, we derive exact conditions for advertising and R&D being substitute … strategies for the incumbent firm and show that it may overinvest in advertising to reduce the incentive for an entrant to invest …
Persistent link: https://www.econbiz.de/10013316463
Cover Image
Push-Me Pull-You : Comparative Advertising in the OTC Analgesics Industry
Anderson, Simon P. - 2015
We derive equilibrium incentives to use comparative advertising that pushes up own brand perception and pulls down the … matrices identify diversion ratios, from which we derive comparative advertising damage measures. We find that comparative … advertising causes more damage to the targeted rival than benefit to the advertiser. We simulate banning comparative advertising …
Persistent link: https://www.econbiz.de/10013019411
Cover Image
Sustainable Reimbursements : Towards a Unified Framework for Pricing Drugs with Significant Uncertainties
Chassang, Sylvain - 2018
Recent political events have thrust the bulk negotiation of drug prices by Medicare and Medicaid back into the spotlight. Yet, even if politically feasible, there is no clear framework for negotiating prices of new drugs with uncertain target populations — for example, due to imprecise...
Persistent link: https://www.econbiz.de/10012925248
Cover Image
Margins and Market Shares : Pharmacy Incentives for Generic Substitution
Brekke, Kurt Richard - 2013
generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …
Persistent link: https://www.econbiz.de/10013088216
Cover Image
Explaining Early Adoption on New Medicines : Regulation, Innovation and Scale
Varol, Nebibe - 2014
Understanding how price regulations affect the adoption of new patent-protected pharmaceutical technologies is a crucial question in designing health systems. This paper addresses this question by examining how price expectations shape the probability of launch, controlling for competition,...
Persistent link: https://www.econbiz.de/10013067984
Cover Image
Does Pharmaceutical Price Regulation Affect the Adoption of Generic Competition? Evidence from the OECD, 1999-2008
Varol, Nebibe - 2014
Generic competition in the pharmaceutical market is an effective cost-containment mechanism that improves static efficiency and stimulates pharmaceutical innovation. There is no prior study that has empirically analysed the relative delays in adoption of generic competition. This paper aims to...
Persistent link: https://www.econbiz.de/10013068052
Cover Image
Reference Pricing, Competition, and Pharmaceutical Expenditures : Theory and Evidence from a Natural Experiment
Brekke, Kurt Richard; Holmas, Tor Helge; Straume, Odd Rune - 2021
We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. First, we construct a vertical...
Persistent link: https://www.econbiz.de/10013316129
Cover Image
Reference Pricing of Pharmaceuticals
Brekke, Kurt Richard; Königbauer, Ingrid; Straume, Odd Rune - 2021
We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry...
Persistent link: https://www.econbiz.de/10013317373
Cover Image
Price Regulation and Parallel Imports of Pharmaceuticals
Brekke, Kurt Richard - 2015
This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a theory model where the producer price is subject to bargaining between the brand-name producer and a distributor, we show that the effects of stricter price regulation crucially...
Persistent link: https://www.econbiz.de/10013017702
Cover Image
A Probability Approach to Pharmaceutical Demand and Price Setting : Does the Identity of the Third-Party Payer Matters for Prescribing Doctors?
Dalen, Dag Morten - 2011
TNF-alpha inhibitors represent one of the most important areas of biopharmaceuticals by sales, with three blockbusters accounting for 8 per cent of total pharmaceutical sale in Norway. Novelty of the paper is to examine, with the use of a unique natural policy experiment in Norway, to what...
Persistent link: https://www.econbiz.de/10013118139